As of 2026-03-20, the Relative Valuation of Relay Therapeutics Inc (RLAY) is (34.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.00 USD, the upside of Relay Therapeutics Inc based on Relative Valuation is -440.7%.
The range of the Relative Valuation is (32.49) - (34.03) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.6x - 24.5x | 22.6x |
| Forward P/E multiples | 21.0x - 22.0x | 21.5x |
| Fair Price | (32.49) - (34.03) | (34.07) |
| Upside | -424.9% - -440.3% | -440.7% |
| Date | P/E |
| 2026-03-13 | -6.70 |
| 2026-03-12 | -6.82 |
| 2026-03-11 | -6.98 |
| 2026-03-10 | -6.91 |
| 2026-03-09 | -6.56 |
| 2026-03-06 | -6.39 |
| 2026-03-05 | -6.23 |
| 2026-03-04 | -6.56 |
| 2026-03-03 | -6.37 |
| 2026-03-02 | -6.33 |
| 2026-02-27 | -6.63 |
| 2026-02-26 | -5.92 |
| 2026-02-25 | -5.96 |
| 2026-02-24 | -5.93 |
| 2026-02-23 | -5.78 |
| 2026-02-20 | -5.62 |
| 2026-02-19 | -5.73 |
| 2026-02-18 | -5.88 |
| 2026-02-17 | -5.92 |
| 2026-02-13 | -5.77 |
| 2026-02-12 | -5.70 |
| 2026-02-11 | -5.92 |
| 2026-02-10 | -5.81 |
| 2026-02-09 | -5.59 |
| 2026-02-06 | -5.77 |
| 2026-02-05 | -5.27 |
| 2026-02-04 | -5.49 |
| 2026-02-03 | -5.60 |
| 2026-02-02 | -5.27 |
| 2026-01-30 | -4.95 |
| 2026-01-29 | -4.98 |
| 2026-01-28 | -4.95 |
| 2026-01-27 | -5.49 |
| 2026-01-26 | -4.91 |
| 2026-01-23 | -4.80 |
| 2026-01-22 | -4.91 |
| 2026-01-21 | -4.87 |
| 2026-01-20 | -4.79 |
| 2026-01-16 | -4.75 |
| 2026-01-15 | -4.93 |
| 2026-01-14 | -5.22 |
| 2026-01-13 | -5.13 |
| 2026-01-12 | -5.04 |
| 2026-01-09 | -5.17 |
| 2026-01-08 | -5.17 |
| 2026-01-07 | -5.29 |
| 2026-01-06 | -5.28 |
| 2026-01-05 | -5.08 |
| 2026-01-02 | -5.29 |
| 2025-12-31 | -5.47 |